Filing Details
- Accession Number:
- 0001127602-16-048950
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-06 17:19:22
- Reporting Period:
- 2016-04-04
- Filing Date:
- 2016-04-06
- Accepted Time:
- 2016-04-06 17:19:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1575229 | Charles Dadswell | 5200 Illumina Way San Diego CA 92122 | Sr Vp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-04-04 | 3,271 | $167.08 | 54,970 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-04-04 | 3,751 | $167.99 | 51,219 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-04-04 | 1,360 | $169.10 | 49,859 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 3,271 shares sold ranging from $166.47 to $167.45 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 3,751 shares sold ranging from $167.57 to $168.54 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,360 shares sold ranging from $168.61 to $169.47 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.